Janus Henderson Global Life Sciences Fund

A $acc ISIN code: IE0009355771

Ratings and awards

Morningstar 5 Star

Investment objective

This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve similar or lower volatility relative to our peers.

Overview

The value of an investment and the income from it can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.

Potential investors must read the prospectus, and where relevant, the key investor information document before investing.

This website is for financial promotion purposes and is not investment advice.

Before you invest

Share class:

Key documents

All documents
ISIN code: IE0009355771A $acc Currency USD NAV 34.6400 Change
-
Price date 25/06/2019
 
ISIN code: IE0002122038A €acc Hedged Currency EUR NAV 31.9200 Change
-
Price date 25/06/2019
ISIN code: IE00BRJG7840U €acc Currency EUR NAV 17.3800 Change
-
Price date 25/06/2019
ISIN code: IE00BFRSYK98U €acc Hedged Currency EUR NAV 18.3800 Change
-
Price date 25/06/2019
ISIN code: IE00BFRSYJ83U$acc Currency USD NAV 20.0600 Change
-
Price date 25/06/2019
Performance

Past performance is not a guide to future performance. All performance data includes both income and capital gains or losses and reflects the deduction of any ongoing charges or other fund expenses.

Discrete performance

Share classMar 2018 - Mar 2019Mar 2017 - Mar 2018Mar 2016 - Mar 2017Mar 2015 - Mar 2016Mar 2014 - Mar 2015
A $acc12.23%11.74%11.52%-19.28%39.07%
A €acc Hedged8.58%8.90%9.32%-19.53%38.78%
U €acc24.88%-1.68%20.63%-22.63%-
U €acc Hedged10.15%10.49%10.82%-18.28%40.67%
U$acc13.85%13.38%13.17%-18.09%41.08%
© Morningstar 2018. All rights reserved. NAV-NAV, gross income reinvested where applicable.Source: Morningstar, based on market prices at close on the date shown. We are not responsible for the accuracy or completeness of the information supplied by Morningstar. We take care to ensure that the information provided by Morningstar is correct but we neither warrant, represent nor guarantee the contents of the information, nor do we accept any responsibility for errors, inaccuracies, omissions or any inconsistencies therein. Prices may be subject to change, errors and omissions excepted. Annual return to 31/03/2019

Cumulative performance

Share classLast monthYTD1 Year3 YearsSince inception
A $acc3.4313.50%6.78%37.68%246.40%
A €acc Hedged3.1011.57%3.17%26.57%219.20%
U €acc2.1815.25%11.55%40.27%73.80%
U €acc Hedged3.2012.35%4.67%32.14%83.80%
U$acc3.5614.30%8.32%43.70%100.60%
© Morningstar 2018. All rights reserved. NAV-NAV, gross income reinvested where applicable.Source: Morningstar, based on market prices at close on the date shown. We are not responsible for the accuracy or completeness of the information supplied by Morningstar. We take care to ensure that the information provided by Morningstar is correct but we neither warrant, represent nor guarantee the contents of the information, nor do we accept any responsibility for errors, inaccuracies, omissions or any inconsistencies therein. Prices may be subject to change, errors and omissions excepted. Data as at 25/06/2019
Top 10 holdings
Geographic breakdown
Sector breakdown
Dividends
Key data
Asset class Equities
Structure Irish Investment Company
Launch date 31/03/2000
Base currency USD
Sector Morningstar Europe OE Sector Equity Healthcare
Benchmark MSCI World Health Care
Pricing basis -

A $acc

Distribution type Accumulation
ISIN code IE0009355771
WKN Code 935590
Valoren Code 1060639
Initial charge 5
Annual charges 1.5
Launch date 31/03/2000
Dividend pay dates N/A
XD dates N/A
Currency USD
Performance FeeCertain classes within a fund may be able to charge a performance related management fee, which becomes payable when that class outperforms its performance fee benchmark and previous high watermark (where applicable).An indication of the historic performance fee payable can be found in the relevant KIID.N/A
Minimum Lump Sum USD2,500.00

A €acc Hedged

Distribution type Accumulation
ISIN code IE0002122038
WKN Code 935591
Valoren Code 1060678
Initial charge 5
Annual charges 1.5
Launch date 31/03/2000
Dividend pay dates N/A
XD dates N/A
Currency EUR
Performance FeeCertain classes within a fund may be able to charge a performance related management fee, which becomes payable when that class outperforms its performance fee benchmark and previous high watermark (where applicable).An indication of the historic performance fee payable can be found in the relevant KIID.N/A
Minimum Lump Sum EUR2,500.00

U €acc

Distribution type Accumulation
ISIN code IE00BRJG7840
WKN Code A2APCY
Valoren Code 25825798
Initial charge N/A
Annual charges 0.8
Launch date 20/10/2014
Dividend pay dates N/A
XD dates N/A
Currency EUR
Performance FeeCertain classes within a fund may be able to charge a performance related management fee, which becomes payable when that class outperforms its performance fee benchmark and previous high watermark (where applicable).An indication of the historic performance fee payable can be found in the relevant KIID.N/A
Minimum Lump Sum EUR2,500.00

U €acc Hedged

Distribution type Accumulation
ISIN code IE00BFRSYK98
WKN Code A117BV
Valoren Code 22772880
Initial charge 0
Annual charges 0.8
Launch date 31/10/2013
Dividend pay dates N/A
XD dates N/A
Currency EUR
Performance FeeCertain classes within a fund may be able to charge a performance related management fee, which becomes payable when that class outperforms its performance fee benchmark and previous high watermark (where applicable).An indication of the historic performance fee payable can be found in the relevant KIID.N/A
Minimum Lump Sum EUR2,500.00

U$acc

Distribution type Accumulation
ISIN code IE00BFRSYJ83
Valoren Code 22772753
Initial charge 0
Annual charges 0.8
Launch date 31/10/2013
Dividend pay dates N/A
XD dates N/A
Currency USD
Performance FeeCertain classes within a fund may be able to charge a performance related management fee, which becomes payable when that class outperforms its performance fee benchmark and previous high watermark (where applicable).An indication of the historic performance fee payable can be found in the relevant KIID.N/A
Minimum Lump Sum USD2,500.00

Manager(s)

General risks
  • ​The value of the Funds and the income from them is not guaranteed and may fall as well as rise. You may get back less than you originally invested.
  • ​Past performance is not a guide to future performance.
  • ​For detailed product information including the risks associated with investing please read the relevant Prospectus or Annual Report.
  • Before investing in any of our funds you should satisfy yourself as to the suitability and the risks involved, you may wish to consult a financial adviser.
  • Third party data is believed to be reliable, but its completeness and accuracy is not guaranteed.
Specific risks
  • This fund is designed to be used only as one component of several in a diversified investment portfolio. Investors should consider carefully the proportion of their portfolio invested into this fund.
  • If a Fund has a high exposure to a particular country or geographical region it carries a higher level of risk than a Fund which is more broadly diversified.
  • The Fund may use derivatives with the aim of reducing risk or managing the portfolio more efficiently. However this introduces other risks, in particular, that a derivative counterparty may not meet its contractual obligations.
  • Shares can lose value rapidly, and typically involve higher risks than bonds or money market instruments. The value of your investment may fall as a result.
  • If the Fund holds assets in currencies other than the base currency of the Fund or you invest in a share class of a different currency to the Fund (unless 'hedged'), the value of your investment may be impacted by changes in exchange rates.
  • The Fund is focused towards particular industries or investment themes and may be heavily impacted by factors such as changes in government regulation, increased price competition, technological advancements and other adverse events.
  • Shares of small and mid-size companies can be more volatile than shares of larger companies, and at times it may be difficult to value or to sell shares at desired times and prices, increasing the risk of losses.

Announcements

Important message